UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1.50 Improving Safe Medication Storage to Prevent Youth Overdose Deaths: The Lock Bag Program

Journal of the American Academy of Child and Adolescent Psychiatry, 2024-10, Vol.63 (10), p.S174-S174

2024

Volltextzugriff (PDF)

6.74 The Relationship Between Adversity History and PTSD in Transitional-Age Youth

Journal of the American Academy of Child and Adolescent Psychiatry, 2024-10, Vol.63 (10), p.S304-S304

2024

Volltextzugriff (PDF)

Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial

The Lancet. Haematology, 2024-09

2024

Volltextzugriff (PDF)

The “Hector” case and the community rehabilitation of offenders with Intellectual Disability and psychiatric disorders

European psychiatry, 2024-08, Vol.67 (S1), p.S30-S30

2024

Volltextzugriff (PDF)

Cesare Cases e la didattica della letteratura

L'ospite ingrato, 2024-07, Vol.15 (I), p.47-62

Santarone, Donatello

2024

Volltextzugriff (PDF)

Myelofibrosis and allogeneic transplantation: critical points and challenges

Frontiers in oncology, 2024-06, Vol.14, p.1396435

2024

Volltextzugriff (PDF)

Higher cyclophosphamide dose grants optimal stem cell collection after daratumumab-based induction in multiple myeloma

Haematologica (Roma), 2023-12, Vol.108 (12), p.3502-3505

2023

Volltextzugriff (PDF)

Phase II Study on Venetoclax (Ven) Plus Decitabine (Dec) (Ven-Dec) for Elderly (≥60 <75years) Patients with Newly Diagnosed High-Intermediate Risk Acute Myeloid Leukemia (AML) Elegible for Allogeneic Stem Cell Transplantation: Final Report of Ven DEC GITMO Study

Blood, 2023-11, Vol.142 (Supplement 1), p.1513-1513

2023

Volltextzugriff (PDF)

Daratumumab-based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia

EJHaem, 2023-11, Vol.4 (4), p.1152-1156

2023

Volltextzugriff (PDF)

Cognitive dysfunction and psychopathology: a cohort study of adults with intellectual developmental disorder

Journal of intellectual disability research, 2023-10, Vol.67 (10), p.1029-1045

2023

Volltextzugriff (PDF)

Secondary Malignancies in Patients after Allogeneic Hematopoietic Cell Transplantation at Triple the Incidence of Malignancies in Their Family Donors

Annals of hematology & oncology, 2023-09, Vol.10 (5)

2023

Volltextzugriff (PDF)

P965: STEM‐CELL MOBILIZATION WITH CYCLOPHOSPHAMIDE 4 G/M2 ALLOWS COLLECTION OF HIGH NUMBERS OF CD34+ CELLS AFTER DARA‐VTD INDUCTION FOR MULTIPLE MYELOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e05968ba-n/a

2023

Volltextzugriff (PDF)

OS-124-YI - Diagnosis by liver stiffness measurement of sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation: results from the Italian multicentric prospective study (ELASTOVOD)

Journal of hepatology, 2023-06, Vol.78, p.S94-S95

2023

Volltextzugriff (PDF)

Diagnosis by liver stiffness measurement of sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation: results from the Italian multicentric prospective study (ELASTOVOD)

Journal of hepatology, 2023-06, Vol.78, p.S94-S95

2023

Volltextzugriff (PDF)

P24 HIGH‐DOSE CYCLOPHOSPHAMIDE 4 GR/M2 AND STEM‐CELL COLLECTION AFTER DARATUMUMAB‐BASED QUADRUPLET INDUCTION IN NEWLY DIAGNOSED TRANSPLANT‐ELIGIBLE MULTIPLE MYELOMA PATIENTS: A SINGLE‐CENTER EXPERIENCE

HemaSphere, 2023-05, Vol.7 (S2), p.23-23

2023

Volltextzugriff (PDF)

Fatigue as Mediator Factor in PTSD-Symptoms after Allogeneic Hematopoietic Stem Cell Transplantation

Journal of clinical medicine, 2023-04, Vol.12 (8), p.2756

2023

Volltextzugriff (PDF)

Specific cognitive dysfunctioning and vulnerability to specific psychopathology: A descriptive study on intellectual developmental disorder (intellectual disability)

European psychiatry, 2023-03, Vol.66 (S1), p.S148-S149

2023

Volltextzugriff (PDF)

Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study

Transplantation direct, 2023-03, Vol.9 (3), p.e1451-e1451

2023

Volltextzugriff (PDF)

1 – 25 von 254

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(213)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

1.50 Improving Safe Medication Storage to Prevent Youth Overdose Deaths: The Lock Bag Program

6.74 The Relationship Between Adversity History and PTSD in Transitional-Age Youth

Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial

Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party

Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial

The “Hector” case and the community rehabilitation of offenders with Intellectual Disability and psychiatric disorders

Cesare Cases e la didattica della letteratura

Myelofibrosis and allogeneic transplantation: critical points and challenges

Higher cyclophosphamide dose grants optimal stem cell collection after daratumumab-based induction in multiple myeloma

Graft-Versus-Host Disease (GvHD) and Steroid-Refractory GvHD after Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World EBMT-Based Epidemiology and Treatment Pattern Study

Phase II Study on Venetoclax (Ven) Plus Decitabine (Dec) (Ven-Dec) for Elderly (≥60 <75years) Patients with Newly Diagnosed High-Intermediate Risk Acute Myeloid Leukemia (AML) Elegible for Allogeneic Stem Cell Transplantation: Final Report of Ven DEC GITMO Study

Daratumumab-based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia

Cognitive dysfunction and psychopathology: a cohort study of adults with intellectual developmental disorder

Secondary Malignancies in Patients after Allogeneic Hematopoietic Cell Transplantation at Triple the Incidence of Malignancies in Their Family Donors

P1539: INFECTION‐RELATED MORTALITY CLINICAL‐BIOLOGICAL SCORING SYSTEM (IRM‐SCORE) AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A VALIDATION STUDY IN GITMO CENTRES

P965: STEM‐CELL MOBILIZATION WITH CYCLOPHOSPHAMIDE 4 G/M2 ALLOWS COLLECTION OF HIGH NUMBERS OF CD34+ CELLS AFTER DARA‐VTD INDUCTION FOR MULTIPLE MYELOMA

P502: PHASE II STUDY ON VENETOCLAX PLUS DECITABINE FOR ELDERLY (≥60 <75YEARS) PATIENTS WITH NEWLY DIAGNOSED HIGH‐INTERMEDIATE RISK AML ELEGIBLE FOR ALLO‐SCT: MIDTERM UPDATE OF VEN‐DEC GITMO STUDY

A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect

OS-124-YI - Diagnosis by liver stiffness measurement of sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation: results from the Italian multicentric prospective study (ELASTOVOD)

Diagnosis by liver stiffness measurement of sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation: results from the Italian multicentric prospective study (ELASTOVOD)

P24 HIGH‐DOSE CYCLOPHOSPHAMIDE 4 GR/M2 AND STEM‐CELL COLLECTION AFTER DARATUMUMAB‐BASED QUADRUPLET INDUCTION IN NEWLY DIAGNOSED TRANSPLANT‐ELIGIBLE MULTIPLE MYELOMA PATIENTS: A SINGLE‐CENTER EXPERIENCE

Fatigue as Mediator Factor in PTSD-Symptoms after Allogeneic Hematopoietic Stem Cell Transplantation

Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling

Specific cognitive dysfunctioning and vulnerability to specific psychopathology: A descriptive study on intellectual developmental disorder (intellectual disability)

Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study

Suchergebnisse filtern